Washington Post, Americans spent $71 billion on GLP-1 drugs in 2023 (Apr. 21, 2025)

[keangkong]

Washington Post, Americans spent $71 billion on GLP-1 drugs in 2023 - 
Spending on Ozempic, Wegovy and similar prescriptions soared 500 percent in five years, according to a research letter (Apr. 21, 2025), unlocked article.

https://wapo.st/3RN38jj

 

[Calm Logic]

From the article: "Also in 2023, products that were approved to treat Type 2 diabetes accounted for 89 percent of all spending."

So, per Google Gemini: "This suggests that while some GLP-1 drugs are also approved for weight loss, the primary driver of the massive spending in 2023 was the use of these drugs for diabetes management."

 

[keangkong]

This data is from 2023. Obviously the numbers will turn out to be much larger for 2024.